Market Capitalization (Millions $) |
41 |
Shares
Outstanding (Millions) |
6 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
2 |
Cash Flow (TTM) (Millions $) |
36 |
Capital Exp. (TTM) (Millions $) |
0 |
Landos Biopharma Inc
Landos Biopharma Inc is a biotechnology company that focuses on developing and commercializing novel therapeutics for autoimmune diseases. The company specializes in utilizing its proprietary platform, called LANCE, to discover and develop oral peptide-based therapies that target specific disease pathways. Landos Biopharma aims to improve the quality of life for patients suffering from autoimmune diseases by providing effective and convenient treatment options.
Company Address: 1800 Kraft Drive Blacksburg 24060 VA
Company Phone Number: 218-2232 Stock Exchange / Ticker: NASDAQ LABP
LABP is expected to report next financial results on March 22, 2024. |
|
|